Purdue Pharma’s former president Richard Sackler, MD, knew his company’s opioid painkiller OxyContin was being abused, but still pushed sales to physicians and tried to divert the blame to patients ...

PARIS -- A unit of French advertising giant Publicis Groupe SA agreed Thursday to pay $350 million to settle claims it helped OxyContin maker Purdue Pharma fuel the opioid epidemic in the United ...

Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no longer fully protects the company’s owners, members of the Sackler families, from ...

This article was written for and originally appeared in Issue 19 December 2024, of The Receiver, a publication of the National Association of Federal Equity Receivers (NAFER), and is being reproduced ...

Purdue Pharma on Wednesday filed a new Chapter 11 reorganization plan with the U.S. Bankruptcy Court for the Southern District of New York to settle opioid-related claims involving the company for ...

Add Yahoo as a preferred source to see more of our stories on Google. Attorneys have filed more than 360 claims for West Virginia children born with opioid dependency after the approval of Purdue ...

WASHINGTON — Purdue Pharma has gained support from attorneys general in 55 U.S. states and territories for a $7.4 billion settlement aimed at resolving thousands of lawsuits related to the opioid ...

NEW YORK – A federal bankruptcy judge said on Friday he will approve a restructuring plan for drugmaker Purdue Pharma that includes a $7.4 billion settlement resolving claims that it fueled the U.S.

Purdue Pharma on Wednesday filed a new bankruptcy reorganization plan to resolve mass lawsuits alleging that the OxyContin maker and its Sackler family owners contributed to the opioid crisis. Here ...

STAMFORD — U.S. states’ claims in Purdue Pharma’s bankruptcy case total approximately $2.2 trillion. Any settlement amount reached with the company, however, will likely be for far less. The company ...

Activist Ryan Hampton sees a major flaw in the proposed $7.4 billion bankruptcy settlement reached by the OxyContin maker. While it's potentially one of the largest opioid settlements ever, he says ...